Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:57:269-289.
doi: 10.1007/7854_2022_339.

Epigenetics and ADHD

Affiliations

Epigenetics and ADHD

Timothy Silk et al. Curr Top Behav Neurosci. 2022.

Abstract

There is robust evidence of genetic susceptibility to Attention-Deficit Hyperactivity Disorder (ADHD); however, there still remains significant variability that is not attributable to genetic factors. The emerging field of epigenetics is beginning to reveal how genotypic expression can be mediated by an array of variables including external environmental exposure, inter-individual developmental variation, and by the genome itself. Epigenetic modification plays a central role in neurobiological and developmental processes, and disturbances to these processes can have implications for a range of mental health problems. Although the field is still in its early days, this chapter will discuss the current standing of epigenetic research into ADHD. Firstly, key relevant epigenetic processes will be discussed. This will be followed by an overview of the key findings to date investigating the role of epigenetics in ADHD. Human studies have included the theory-driven approach of candidate-gene studies (CGS), as well as the increasingly popular exploratory approach of epigenome-wide association studies (EWAS). Overall, the findings are heterogeneous. However, it is possible that with more longitudinal studies and better characterised cohorts, both predictive and protective links between epigenetic processes and ADHD will be revealed.

Keywords: Candidate gene; EWAS; Epigenetic; Epigenome; Methylation.

PubMed Disclaimer

References

    1. Adriani W, Romano E, Pucci M et al (2018) Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity. Eur Child Adolesc Psychiatry 27:241–252. https://doi.org/10.1007/s00787-017-1040-9 - DOI - PubMed
    1. Ali I, Conrad RJ, Verdin E, Ott M (2018) Lysine acetylation goes global: from epigenetics to metabolism and therapeutics. Chem Rev 118:1216–1252. https://doi.org/10.1021/acs.chemrev.7b00181 - DOI - PubMed - PMC
    1. Bakulski KM, Halladay A, Hu VW et al (2016) Epigenetic research in neuropsychiatric disorders: the “Tissue Issue”. Curr Behav Neurosci Rep 3:264–274. https://doi.org/10.1007/s40473-016-0083-4 - DOI - PubMed - PMC
    1. Beaver KM, Vaughn MG, Delisi M (2013) Nonshared environmental effects on adulthood psychopathic personality traits: results from a monozygotic twin difference scores analysis. Psychiatry Q 84:381–393. https://doi.org/10.1007/s11126-013-9255-5 - DOI
    1. Bell JT, Tsai P-C, Yang T-P et al (2012) Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet 8:e1002629. https://doi.org/10.1371/journal.pgen.1002629 - DOI - PubMed - PMC

LinkOut - more resources